ArticleCells2025

Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer.

Hector Esquer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.